ADV Biosicence, LLC is a Delaware biotech company, with business location in Birmingham, Alabama.  Advanced lentiviral technology was developed to address the 21st century challenge now facing academic research and pharmaceutical industry endower. With the technology, ADV Bioscience, LLC has the capability and expertise to address the entire genes to drug discovery and development paradigm.  Lentivirus-based custom service for improved gene expression, large-scale protein expression, stable cell line establishment, shRNA-mediated gene silence, druggable target discovery and validation, and generation of transgenic mice and human disease models is provided. Our mission is to provide custom service  with novel and advanced lentiviral biotechnology for scientific research and drug target discovery, validation and drug development to academic institutions/universities and pharmaceutical/biotechnology companies, and further develop new therapeutic compounds or biologics.